The outspoken investment banker is the chairman of PolyNovo. The burns treatment company’s chief executive is leaving after a ...

PolyNovo (ASX:PNV) has announced that its chief executive officer, Swami Raote, will officially leave the company in June but ...

Australian biotech company PolyNovo said on Tuesday it has removed its CEO after discussions with the executive last week following media allegations about bullying by the firm's chairman directed at ...

PolyNovo (PNV), a burns treatment company, has announced the immediate departure of its chief executive officer, Swami Raote.

“Managing expectations is very important and getting up proactively on that. Ultimately, situations like this bring about the ...

Polynovo’s strategy revolves around expanding its geographical footprint to increase access to its products and open new hospital accounts. With its geographical reach the firm estimates its ...

Raote will remain employed until June 10, 2025, but non-executive director Robyn Elliott will take over as acting CEO while ...

Polynovo says CEO Swami Raote has ceased to hold that role, following accusations of corporate governance failings levelled ...

No-moat Polynovo’s PNV CEO has stepped down following reports of certain interactions between the chairman, David Williams, ...

Shares in biotech PolyNovo dived like a German Stuka on Friday – down 13 per cent – after management finally fessed up to ...

Despite announcing strong earnings, PolyNovo Limited's ( ASX:PNV ) stock was sluggish. We did some digging and ...

These shares are having a difficult time on Tuesday. But why? The post Why Brickworks, Nickel Industries, Polynovo, and ...